Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Ellis

Showing results (11-20 of 285) with videos related to

Pageof 29
Sort By:
American Journal of Clinical Oncology|August 7, 2003
Role of biologic markers in patient selection and application to disease preventionMitch Dowsett, Matthew J Ellis
Journal of the National Cancer Institute|March 20, 2020
Response to Jézéquel, Patsouris, Guette, et alMeenakshi Anurag, Matthew J Ellis
Oncoscience|October 3, 2017
Defects in mismatch repair: the Achilles heel of estrogen receptor positive breast cancer with intrinsic endocrine therapy resistance?Svasti Haricharan, Matthew J Ellis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
"PIKing" the winner for phosphatidylinositol 3-kinase inhibitors in ErbB2-positive breast cancer: let's not "PTENed" it's easy!Matthew J Ellis, Robert Crowder
Oncology (Williston Park, N.Y.)|March 15, 2014
The Cancer Genome Atlas: clinical applications for breast cancerCynthia X Ma, Matthew J Ellis
Current Medical Research and Opinion|January 30, 2007
Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current dataMatthew J Ellis, Caron E Rigden
Oncology (Williston Park, N.Y.)|May 12, 2004
Neoadjuvant endocrine therapy for breast cancer: an overlooked option?Zee-Wan Wong, Matthew J Ellis
Expert Opinion on Pharmacotherapy|May 9, 2002
Letrozole in the treatment of breast cancerHeather S Shaw, Matthew J Ellis
The New England Journal of Medicine|September 8, 2006
Hematopoietic stem-cell transplantationMatthew J Ellis, Uptal D Patel
Seminars in Oncology|December 6, 2006
Neoadjuvant endocrine therapy for locally advanced breast cancerCynthia X Ma, Matthew J Ellis
Pageof 29

Showing results (11-20 of 285) with videos related to

Sort By:
Pageof 29
American Journal of Clinical Oncology|August 7, 2003
Role of biologic markers in patient selection and application to disease preventionMitch Dowsett, Matthew J Ellis
Journal of the National Cancer Institute|March 20, 2020
Response to Jézéquel, Patsouris, Guette, et alMeenakshi Anurag, Matthew J Ellis
Oncoscience|October 3, 2017
Defects in mismatch repair: the Achilles heel of estrogen receptor positive breast cancer with intrinsic endocrine therapy resistance?Svasti Haricharan, Matthew J Ellis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
"PIKing" the winner for phosphatidylinositol 3-kinase inhibitors in ErbB2-positive breast cancer: let's not "PTENed" it's easy!Matthew J Ellis, Robert Crowder
Oncology (Williston Park, N.Y.)|March 15, 2014
The Cancer Genome Atlas: clinical applications for breast cancerCynthia X Ma, Matthew J Ellis
Current Medical Research and Opinion|January 30, 2007
Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current dataMatthew J Ellis, Caron E Rigden
Oncology (Williston Park, N.Y.)|May 12, 2004
Neoadjuvant endocrine therapy for breast cancer: an overlooked option?Zee-Wan Wong, Matthew J Ellis
Expert Opinion on Pharmacotherapy|May 9, 2002
Letrozole in the treatment of breast cancerHeather S Shaw, Matthew J Ellis
The New England Journal of Medicine|September 8, 2006
Hematopoietic stem-cell transplantationMatthew J Ellis, Uptal D Patel
Seminars in Oncology|December 6, 2006
Neoadjuvant endocrine therapy for locally advanced breast cancerCynthia X Ma, Matthew J Ellis
Pageof 29